Presentation is loading. Please wait.

Presentation is loading. Please wait.

Partners in care to Improve Quality of Life Abboud Bejjani Vice President AbbVie Biopharmaceutical Cairo March 13/2014.

Similar presentations


Presentation on theme: "Partners in care to Improve Quality of Life Abboud Bejjani Vice President AbbVie Biopharmaceutical Cairo March 13/2014."— Presentation transcript:

1 Partners in care to Improve Quality of Life Abboud Bejjani Vice President AbbVie Biopharmaceutical Cairo March 13/2014

2 People Passion Possibilities Vice President Middle East, Africa & Pakistan Who I am? Degree… 15 Years! Consulting

3 People Passion Possibilities A leading global biopharmaceutical company one year old, but carrying 120 years history in research. AbbVie aspires to contribute to Healthcare Sustainability via Innovative Medicines and New Healthcare Solutions. (Chicago Based company) AbbVie… Who We are?

4 People Passion Possibilities AbbVie Way! Leading biopharmaceutical company in the life sciences industry that fosters pharma innovation & competitiveness a long-term, reliable Partner and a key contributor to the economy and healthcare sustainability Responsibly active member of the community

5 People Passion Possibilities AbbVie Part of the Innovative Biopharmaceutical Industry The innovative biopharmaceutical industry represents global leading pharmaceutical research and biotechnology companies Our companies are devoted to discovering new medicines that allow patients to live longer, healthier, and more productive lives In 2009, the biopharmaceutical sector invested approximately $65.3 billion in research and development

6 People Passion Possibilities Biopharmaceutical Companies’ Investment in R&D Increasing Steadily Total Biopharmaceutical Company R&D and PhRMA Member R&D: 1995– Sources: 1 Burrill & Company, analysis for PhRMA, 2005–2009; Pharmaceutical Research and Manufacturers of America, PhRMA Annual Member Survey (Washington, DC: PhRMA, ); 2 CBO, Research and Development in the Pharmaceutical Industry, The pharmaceutical industry is one of the most research-intensive industries in the United States. Pharmaceutical firms invest as much as five times more in research and development, relative to their sales, than the average U.S. manufacturing firm. 2 — Congressional Budget Office “ “

7 People Passion Possibilities AbbVie Leading Therapeutical Areas & Research Focus 1.Immunology Rheumatoid Arthritis Ankylosing Spondylitis Psoriasis Crohn’s Disease 2.Neonatology (preterm babies) 3. Anesthesia 4.Antiviral (HIV/HCV) 5.Renal Disease 6.Central Nervous System 7.Oncology

8 People Passion Possibilities Can we Partner ? AbbVie & The Arab World Long Term Relation Ship Over 60 years of PartnerShip! Partners in care to Improve Quality of Life

9 People Passion Possibilities Health Authorities’ Objectives ObjectiveHowConsequence By Improving Longevity and Quality of Life By Widening Access To Care Manage rising Healthcare costs Higher Quality Care

10 People Passion Possibilities How we can help? Technology and knowledge transfer Improve patient access to innovative medicines and as results improve patient outcomes Improve efficiency of healthcare delivery Anticipate in boosting the economy by local investments Create high quality jobs

11 People Passion Possibilities Improve patient access to innovative medicines and as results improve patient outcomes Prescription medicines play a major role in saving and improving lives Over the last 25 years, prescription medicines have significantly reduced deaths from major diseases such as heart disease, several cancers, and HIV /AIDS Improved the quality of lives of people suffering from conditions such as arthritis disease. Currently we are talking about full remission from Many Immune Diseases such as Crohn’s, Rheumatoid Arthritis, Psoriasis, Parkinson, needless to mention the prematurity solutions for babies…etc… Recent advances include a new generation of personalized medicines, treatment for some rare diseases and cure for infections like Hepatitis C.

12 People Passion Possibilities Major Advances in Treatment and Prevention Since 1980 life expectancy for cancer patients has increased by 3 years. Research finds that medicines alone account for 50-60% of survival increases. Thanks in part to new medicines, heart failure and heart attack deaths fell by 45% in just the last decade. Within three years of introduction of the first antiretroviral treatments, HIV/AIDS deaths dropped by nearly 70%. “The rapid increases that have been observed in drug-related R&D spending have been accompanied by major therapeutic gains in available drug treatments.” CBO,

13 People Passion Possibilities HIV/AIDS: Decline in Death rates

14 People Passion Possibilities U.S. Life Expectancy

15 People Passion Possibilities How we can help? Technology and knowledge transfer Improve patient access to innovative medicines and as results improve patient outcomes Improve efficiency of healthcare delivery Anticipate in boosting the economy by local investments Create high quality jobs

16 People Passion Possibilities Improving Efficiency of Healthcare Delivery Efficient management of Non Communicable Diseases through : Health education Disease management programs Patient screening programs Eradication of communicable diseases Early introduction of innovative therapeutic options Continuous medical education of HCP Training of healthcare professionals

17 People Passion Possibilities Some Real Life Examples of Health Education– IMID Congress IMID – Immune Mediated Inflammatory Disorders Congress 5% -7% MEA population is afflicted Treated and managed by multi-specialists like Rheumatologists, Dermatologists, Gastroenterologists, Ophthalmologists and Internists who have little time and opportunity to communicate with each other. IMID Congress created a multispecialty platform to bring these specialists together to discuss the latest developments and research to achieve improved patient outcomes. Result: Increased referrals of patients across the specialties that facilitates better co-management of patients.

18 People Passion Possibilities Improving Efficiency of Healthcare Delivery Efficient management of Non Communicable Diseases through : Health education Disease management programs Patient screening programs Eradication of communicable diseases Early introduction of innovative therapeutic options Continuous medical education of HCP Training of healthcare professionals Public Awareness

19 People Passion Possibilities AbbVie partnered with GENERAL Electric to support continuous education of Rheumatologists who were interested in learning ultrasound of the joints. This education was the first of its kind in the MEA and helped to improve the standard of care of the RA patients and support the physician in diagnosis and monitoring of the disease. Result: Rheumatologists started using US in practice and ultrasound became increasingly recognized as a standard tool for diagnosing and treating the aggressive disease early. Some Real Life Examples of what we did – Academy of Imaging

20 People Passion Possibilities Improving Efficiency of Healthcare Delivery Efficient management of Non Communicable Diseases through : Health education Disease management programs Patient screening programs Eradication of communicable diseases Early introduction of innovative therapeutic options Continuous medical education of HCP Training of healthcare professionals Public Awareness

21 People Passion Possibilities Some Real Life Examples of what we did – Patient Support Program Patient Support Specialists (trained physicians and pharmacists by qualification) educate patients on disease understanding and elevate awareness on possible detrimental outcomes if left untreated. In addition: Organize patients’ days whereby consultants are invited to educate patients Advise patients to follow up with Physiotherapists Organize meetings of patients with Nutritionists to learn about optimal diet regime. Facilitate appointment with Psychiatrists for the depressed Ps patients if needed The program is endorsed by MOH and Health Authorities Received endorsement of the Her Royal Highness Princess Oraib Al Saud (daughter of HH Saudi King) to endorse a valuable program aimed to raise prematurity awareness and to call for action to set the healthcare standards of Neonatology in Saudi. The program is supported by many other corporate partners.

22 People Passion Possibilities How we can help? Technology and knowledge transfer Improve patient access to innovative medicines and as results improve patient outcomes Improve efficiency of healthcare delivery Anticipate in boosting the economy by local investments Create high quality jobs

23 People Passion Possibilities Health Authorities’ Objectives ObjectiveHowConsequence Improve Longevity and Quality of Life Wider Access To Care Manage rising Healthcare costs Higher Quality Care

24 People Passion Possibilities How we can help?

25 People Passion Possibilities PPP: Elements of Success ! Trust Transparency Open Dialogue

26 People Passion Possibilities What is required from our side! Trust Transparency Open Dialogue More discussion Don’t be afraid! Show what we do Better Understanding of your challenges

27 People Passion Possibilities What we like you to do! Trust Transparency Open Dialogue Open hears for Pharma Economics Discussion Pharma As a Cost component of Health Bill Better Understanding of our challenges

28 People Passion Possibilities What we like you to do! Trust Transparency Open Dialogue Open hears for Pharma Economics Discussion Pharma As a Cost component of Health Bill Better Understanding of our challenges

29 People Passion Possibilities Industry Concern : Valuable But Vulnerable 29 Limitless Opportunities Growing Challenge

30 People Passion Possibilities 30 DO YOU KNOW?? Developing a new medicine is lengthy, risky, and costly. New drug development takes an average of 10–15 years, and costs approx. US $1.3 billion. INDEFINITE Drug DiscoveryPreclinicalClinical TrialsFDA ReviewScale-Up to Mfg. Post-Marketing Surveillance ONE FDA- APPROVED DRUG 0.5 – 2 YEARS 6 – 7 YEARS3 – 6 YEARS NUMBER OF VOLUNTEERS PHASE 1 PHASE 2 PHASE ~ 5,000 – 10,000 COMPOUNDS PRE-DISCOVERY 20– –5001,000–5,000 IND SUBMITTED NDA SUBMITTED Sources: Drug Discovery and Development: Understanding the R&D Process,

31 People Passion Possibilities Do you know?? Cost to Develop One New Drug 31 Billions

32 People Passion Possibilities Successfully Approved Commercial Medecines

33 People Passion Possibilities What we like you to do! Trust Transparency Open Dialogue Open hears for Pharma Economics Discussion Pharma As a Cost component of Health Bill Better Understanding of our challenges

34 People Passion Possibilities 34 Medicines can Result in Extraordinary Savings for Patients and Health Systems In the U.S., for example, each prescription saves US $57 in avoidable hospital costs. Diabetes: $1 more spent on diabetes medicines = US $7.10 less spent on other services. High Blood Pressure: In 2002, antihypertensives prevented 833,000 stroke and heart attack hospitalizations, saving US $16.5 billion in medical costs. Asthma: A 10% increase in adherence to asthma medicines in elderly patients leads to a 5% decrease in total annual medical spending. Medicines can reduce health costs by preventing and managing disease Sources: Sources: B.C. Stuart, et al. ”Assessing the Impact of Drug Use on Hospital Costs.”Health Services Research, February 2009; M.C. Sokol, K.A. McGuigan, R.R. Verbrugge, R.S. Epstein, “Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost,” Medical Care, 43 (2005): 6, ; D. Cutler, et al., “The Value of Antihypertensive Drugs: A Perspective on Medical Innovation,” Health Affairs, January/February, 2007; B. Briesacher, et al. “Consequences of Poor Compliance with Biphosphonates,” Bone, R. Balkrishnan, et al., “Self-Reported Health Status, Prophylactic Medication Use, and Healthcare Costs in Older Adults with Asthma,: Journal of the American Geriatric Society, 2002.

35 People Passion Possibilities What we like you to do! Trust Transparency Open Dialogue Open hears for Pharma Economics Discussion Pharma As a Cost component of Health Bill Better Understanding of our challenges

36 People Passion Possibilities Medicines and Health Spending Growth

37 People Passion Possibilities We need Common understanding! Trust Transparency Open Dialogue Common Interest and Better understanding of each other needs

38 People Passion Possibilities Improving Patients’ Health and Quality of Life “ New drugs allow children with rheumatoid arthritis to walk and to go to school. New drugs shrink cancerous tumors and they control the advance of HIV. They prevent or halt heart disease, slow the progression of multiple sclerosis, and cure infectious diseases.” 13 —Mark B. McClellan, M.D., Ph.D., Then-FDA Commissioner, September 2003

39 People Passion Possibilities YES WE ARE PARTNERS!!! Partners in care to Improve Quality of Life

40 THANK YOU


Download ppt "Partners in care to Improve Quality of Life Abboud Bejjani Vice President AbbVie Biopharmaceutical Cairo March 13/2014."

Similar presentations


Ads by Google